ENSILICATED TECHNOLOGIES LTD
Executive Summary
Ensilicated Technologies Ltd is an early-stage biotechnology company with solid net current assets and cash reserves but increasing short-term liabilities and widening losses. The company’s ongoing viability depends on continued investor support amid typical start-up operating losses. No regulatory compliance issues are evident, but investor due diligence should focus on liquidity management and funding sustainability.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 10/09/2510 September 2025 New | Resolutions |
| 10/09/2510 September 2025 New | Memorandum and Articles of Association |
| 05/09/255 September 2025 New | Statement of capital following an allotment of shares on 2025-08-13 |
| 13/08/2513 August 2025 New | Termination of appointment of Benjamin Thomas Miles as a director on 2025-08-08 |
| 13/08/2513 August 2025 New | Appointment of Dr Matthew Nicholas Slade as a director on 2025-08-08 |
| 13/08/2513 August 2025 New | Appointment of Ms Sabine Ficek as a secretary on 2025-08-08 |
| 13/08/2513 August 2025 New | Director's details changed for Dr Matthew Nicholas Slade on 2025-08-08 |
| 13/08/2513 August 2025 New | Termination of appointment of Jennifer Mary Rogers as a director on 2025-08-08 |
| 13/08/2513 August 2025 New | Termination of appointment of Matthew Nicholas Slade as a secretary on 2025-08-08 |
| 12/08/2512 August 2025 New | Confirmation statement made on 2025-07-28 with updates |
| 11/08/2411 August 2024 | Confirmation statement made on 2024-07-28 with updates |
| 31/07/2431 July 2024 | Annual accounts for year ending 31 Jul 2024 |
| 24/07/2424 July 2024 | Sub-division of shares on 2024-04-22 |
| 15/04/2415 April 2024 | Total exemption full accounts made up to 2023-07-31 |
| 16/12/2316 December 2023 | Appointment of Ms Sarah Jane Pollitt as a director on 2023-12-06 |
| 01/08/231 August 2023 | Confirmation statement made on 2023-07-28 with updates |
| 31/07/2331 July 2023 | Annual accounts for year ending 31 Jul 2023 |
| 19/06/2319 June 2023 | Second filing of a statement of capital following an allotment of shares on 2022-12-21 |
| 08/06/238 June 2023 | Micro company accounts made up to 2022-07-31 |
| 06/01/236 January 2023 | Change of share class name or designation |
| 06/01/236 January 2023 | Memorandum and Articles of Association |
| 06/01/236 January 2023 | Resolutions |
| 06/01/236 January 2023 | Resolutions |
| 06/01/236 January 2023 | Resolutions |
| 06/01/236 January 2023 | Resolutions |
| 06/01/236 January 2023 | Particulars of variation of rights attached to shares |
| 04/01/234 January 2023 | Registered office address changed from 1 South 1.13 Department of Chemistry, University of Bath Claverton Down Bath Avon BA2 7AY United Kingdom to Science Creates St Philips Albert Road St. Philips Bristol BS2 0XJ on 2023-01-04 |
| 23/12/2223 December 2022 | Appointment of Mr Richard Haycock as a director on 2022-12-19 |
| 23/12/2223 December 2022 | Statement of capital following an allotment of shares on 2022-12-19 |
| 23/12/2223 December 2022 | Statement of capital following an allotment of shares on 2022-12-19 |
| 23/12/2223 December 2022 | Appointment of The Honourable Alexander Michael Fink as a director on 2022-12-19 |
| 07/10/227 October 2022 | Notification of a person with significant control statement |
| 05/10/225 October 2022 | Cessation of Asel Sartbaeva as a person with significant control on 2022-07-20 |
| 05/10/225 October 2022 | Cessation of Aswin Doekhie as a person with significant control on 2022-07-20 |
| 31/07/2231 July 2022 | Annual accounts for year ending 31 Jul 2022 |
| 29/07/2129 July 2021 | Incorporation |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company